Description
Product Description BML is Lunching Apalunix 60 mg tablet which is an androgen receptor asset indicated for the treatment of cases with Metastatic castration-sensitive prostate cancer Non-metastatic castration resistant prostate cancer. Apalunix workshop by blocking the goods of androgen( a manly reproductive hormone) to stop the growth and spread of cancer cells.
Product Features:
Product Name: Apalunix
general Name: Apalutamide Auberge
expression: Tablet
Available Pack Size: 120’s pot
Available Strength: 60 mg
Enrollments: Available
Reviews
There are no reviews yet.